http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MA-34916-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c89ce4d9ac03f9acd8ddede1162f94d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-366
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-397
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-58
filingDate 2012-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6987941daa62825c6fd1ff3400ceddf0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9aa9aec0a7b14aa7d7a410a0a864496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_553b993ff17a589b7cfd63ab1b54b585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0dbe9bfe4cad11c27cf6fc1ac586535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9154c7b5c6631c654d163fc96674d48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c7dc9edd49c96645e461b930bc6069c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_816e331c9f2999e6be242630783bed42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85b25dbfddeac0a4e92d1c1d2e8290e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_186c93e2b65966d792b5b9759198ff78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5448c304b68339547685163c57a6e7d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ccb7a94bc94271916c58a0c49bb33a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3592d2f056dc598ce15f2f38fdd95779
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22c56335c7064920a2f40dd3fa34bb42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_accb177840153696a367e628d862e737
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcea7facde6fecf8132ee248eb24fbe0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_178b79e06fcb068565246e2acac6aeb8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f537e14100cc1e6f0d7d35455c70581
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9de613d98e3f72edb1eb23d762270967
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88f570508f4b33ee6d7f7e01ff6c10dd
publicationDate 2014-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MA-34916-B1
titleOfInvention NOVEL CYCLIC AZABENZIMIDAZOLE DERIVATIVES USEFUL AS ANTIDIABETIC AGENTS
abstract The present invention relates to novel compounds of Structural Formula (I) which are activators of AMP-protein kinase and are useful in the treatment, prevention and suppression of AMPK-activated protein kinase mediated diseases. The compounds of the present invention are useful in the treatment of type 2 diabetes, hyperglycemia, metabolic syndrome, obesity, hypercholesterolemia and hypertension.
priorityDate 2011-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408734456
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67504

Total number of triples: 50.